142217-80-9

• 常用中文名：6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺
• 常用英文名：6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine
• CAS号：142217-80-9
• 分子式：C₅₃H₄₉N₅O₄
• 分子量：819.987
• 发布时间：2018-12-25 07:36:41
• 更新时间：2026-07-08 11:19:21

名称

• 中文名: 6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺
• 英文名: N-[(4-methoxyphenyl)-diphenylmethyl]-9-[(1S,3S)-2-methylidene-4-phenylmethoxy-3-(phenylmethoxymethyl)cyclopentyl]-6-phenylmethoxypurin-2-amine
• 中文别名: 恩替卡韦E-7,6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺; 6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺6-(BENZYLOXY)-9-((1S,3R,3S)-4-(BENZYLOXY)-3-(BENZYLOXYMETHYL)-2-METHYLENECYCLOPENTYL)-N-((4-METHOXYPHENYL)DIPHENYLMETHYL)-9H-PURIN-2-AMINE; 6-(苄氧基)-9-[(1R,3S,4R)-4-(苄氧基)-3-(苄氧基甲基)-2-亚甲基环戊基]-N-[(4-甲氧基苯基)二苯基甲基]-9H-嘌呤-2-胺; 恩替卡韦杂质55; 6-苄氧基-9-((1S,3R,4S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺N-3; 恩替卡韦-3; 恩替卡韦中间体N7; 恩替卡韦中间体ETB; 6-(苯甲氧基-9-((1S,3S)-4-(苯甲氧基)-3-((苯甲氧基)甲基)-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯甲基)-9H-嘌呤-2-胺; 恩替卡韦中间体N7/6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺; 6-(苄氧基)-9-((1S,3R,4S)-4-(苄氧基)-3-(苄氧基甲基)-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺; 6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2-胺(恩替卡韦中间体N7); 恩替卡韦中间体七; 6-苄氧基-9-((1S,3R,3S)-4-苄氧基-3-苄氧基甲基-2-亚甲基环戊基)-N-((4-甲氧基苯基)二苯基甲基)-9H-嘌呤-2
• 英文别名: Entecavir InterMediate VII; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylene-cyclopenyl)-N-((4-met; 9H-Purin-2-aMine,N-[(4-Methoxyphenyl)diphenylMethyl]-9-[(1S,3R,4S)-2-Methylene-4-(phenylMethoxy)-3-[(phenylMethoxy)Methyl]cyclopentyl]-6-(phenylMethoxy); 6-(Benzyloxy)-9-{(1S,3S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylenecyclopentyl}-N-[(4-methoxyphenyl)(diphenyl)methyl]-9H-purin-2-amine; 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxyMethyl)-2-Methylenecyclopentyl)-N-((4-Methoxyp; Entecavir Impurity 55; 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine(Ent-VII); Entecavir interMediate 7; Entecavir Impurity 15; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)Methyl)-2-Methylenecyclopentyl)-N-((4-Methoxyphenyl)diphenylMethyl)-9H-purin-2-aMine; 6-(benzyloxy)-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine; 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-ami; 6-(Benzyloxy)-9-(1S,3R,3S)-4-(benzyloxy)-3-(benzyoxymethyl)-2-methylenecyclopentyl)-N-N-(4-methyoxyphenyl)diaphenylmethyl)-9H-purin-2-amine; [1S-(1α,3α,4β)]-N-[(4-Methoxyphenyl)diphenyl-Methyl]-6-(phenylMethoxy)-9-[2-Methylene-4-(phenylMethoxy)-3-[(phenylMethoxy)Methyl]-cyclopentyl]-9H-purin-2-aMine; 6-(benzyloxy)-9-(1S,3R,3S)-4-(benzyloxy)_3-(benzyoxymethyl)-2-methylenecyclopentyl)-N-N -(4-methyoxyphenyl)diaphenylmethyl)-9H-purin-2-amino; N-[(4-Methoxyphenyl)diphenylmethyl]-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)me; 6-(Benzyloxy)-9-((1S,3R,3S)-4-(Benzyloxy)-3-(Benzyloxymethyl); Entecavir E7; I06-2209; N-[(4-Methoxyphenyl)diphenylMethyl]-9-[(1S,3R,4S)-2-Methylene-4-(benzyloxy)-3-[(benzyloxy)Methyl]cyclopentyl]-6-(benzyloxy)-9H-Purin-2-aMine; 142-9 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine; Ente-3; 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl)-N-((4-meth; N-[(4-Methoxyphenyl)diphenylmethyl]-9-[(1S,3R,4S)-2-methylene-4-(phenylmethoxy)-3-[(phenylmethoxy)methyl]cyclopentyl]-6-(phenylmethoxy)-9H-purin-2-amine; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyph; 6-(Benzyloxy)-9-[(1R,3S,4R)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylenecyclopentyl]-N-[(4-methoxyphenyl)diphenylmethyl]-9H-purin-2-amine; [2-(4-Methyl-2-phenyl-1-piperazinyl)-3-pyridinyl]Methanol; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylenecyclopentyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylene-cyclopenyl)-N-((4-methox; 6-benzyloxy-9- ((1S, 3R, 3S) -4-benzyloxy-3-benzyloxymethyl-2-methylcyclopentyl) - N - ((4-methoxyphenyl) diphenylmethyl) -9H-purine-2-amine; N-[(4-methoxyphenyl)-diphenylmethyl]-9-[2-methylene-4-phenylmethoxy-3-(phenylmethoxymethyl)cyclopentyl]-6-phenylmethoxy-2-purinamine; ETB/N7; Entecavir-7; 6-(Benzyloxy)-9-((1S,3R,3S)-4-(benzyloxy)-3-(benzyloxyMethyl)-2-Methylenecyclopentyl)-N-((4-Methoxyphenyl)diphenylMethyl)-9H-purin-2-aMine (interMediate 6); 6-(benzyloxy)-9-[(1S,3R,4S)-4-(benzyloxy)-3-[(benzyloxy)methyl]-2-methylidenecyclopentyl]-N-[(4-methoxyphenyl)diphenylmethyl]-9H-purin-2-amine; 6-(Benzyloxy)-9-((1S,3S)-4-(benzyloxy)-3-((benzyloxy)methyl)-2-methylene-cyclopenyl)-N-((4-methoxyphenyl)diphenylmethyl)-9H-purin-2-amine

物化性质

• 密度: 1.2±0.1 g/cm3
• 分子式: C₅₃H₄₉N₅O₄
• 分子量: 819.987
• 精确质量: 819.378479
• PSA: 92.55000
• LogP: 11.00
• 折射率: 1.636
• 储存条件: 2-8°C

合成路线